These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36063275)

  • 1. Identification of potential inhibitors of Zika virus targeting NS3 helicase using molecular dynamics simulations and DFT studies.
    Mishra SS; Kumar N; Karkara BB; Sharma CS; Kalra S
    Mol Divers; 2023 Aug; 27(4):1689-1701. PubMed ID: 36063275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction.
    Li Z; Brecher M; Deng YQ; Zhang J; Sakamuru S; Liu B; Huang R; Koetzner CA; Allen CA; Jones SA; Chen H; Zhang NN; Tian M; Gao F; Lin Q; Banavali N; Zhou J; Boles N; Xia M; Kramer LD; Qin CF; Li H
    Cell Res; 2017 Aug; 27(8):1046-1064. PubMed ID: 28685770
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Cruz-Arreola O; Orduña-Diaz A; Domínguez F; Reyes-Leyva J; Vallejo-Ruiz V; Domínguez-Ramírez L; Santos-López G
    PeerJ; 2022; 10():e13650. PubMed ID: 35945938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists.
    Shiryaev SA; Farhy C; Pinto A; Huang CT; Simonetti N; Elong Ngono A; Dewing A; Shresta S; Pinkerton AB; Cieplak P; Strongin AY; Terskikh AV
    Antiviral Res; 2017 Jul; 143():218-229. PubMed ID: 28461069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
    Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY
    Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and Computational Analyses of Novel Small Molecule Zika Virus Inhibitors.
    Zhu S; Zhang C; Huang LS; Zhang XQ; Xu Y; Fang X; Zhou J; Wu M; Schooley RT; Huang Z; An J
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31013906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The discovery of Zika virus NS2B-NS3 inhibitors with antiviral activity via an integrated virtual screening approach.
    Mirza MU; Alanko I; Vanmeert M; Muzzarelli KM; Salo-Ahen OMH; Abdullah I; Kovari IA; Claes S; De Jonghe S; Schols D; Schinazi RF; Kovari LC; Trant JF; Ahmad S; Froeyen M
    Eur J Pharm Sci; 2022 Aug; 175():106220. PubMed ID: 35618201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the NTPase site of Zika virus NS3 helicase for inhibitor discovery.
    Kumar D; Aarthy M; Kumar P; Singh SK; Uversky VN; Giri R
    J Biomol Struct Dyn; 2020 Oct; 38(16):4827-4837. PubMed ID: 31690231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease.
    Akaberi D; Chinthakindi PK; Båhlström A; Palanisamy N; Sandström A; Lundkvist Å; Lennerstrand J
    J Biomol Struct Dyn; 2020 Nov; 38(18):5526-5536. PubMed ID: 31880199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanism of ATP and RNA binding to Zika virus NS3 helicase and identification of repurposed drugs using molecular dynamics simulations.
    Durgam L; Guruprasad L
    J Biomol Struct Dyn; 2022; 40(23):12642-12659. PubMed ID: 34516356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Dynamics of Zika Virus NS2B-NS3 Protease Binding to Dipeptide Inhibitors.
    Li Y; Zhang Z; Phoo WW; Loh YR; Wang W; Liu S; Chen MW; Hung AW; Keller TH; Luo D; Kang C
    Structure; 2017 Aug; 25(8):1242-1250.e3. PubMed ID: 28689970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ellagic Acid as a Potential Inhibitor against the Nonstructural Protein NS3 Helicase of Zika Virus: A Molecular Modelling Study.
    Kullappan M; Benedict BA; Rajajagadeesan A; Baskaran P; Periadurai ND; Ambrose JM; Gandhamaneni SH; Nakkella AK; Agarwal A; Veeraraghavan VP; Surapaneni KM
    Biomed Res Int; 2022; 2022():2044577. PubMed ID: 36046457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Insights into the Inhibition of Zika Virus NS2B-NS3 Protease by a Small-Molecule Inhibitor.
    Li Y; Zhang Z; Phoo WW; Loh YR; Li R; Yang HY; Jansson AE; Hill J; Keller TH; Nacro K; Luo D; Kang C
    Structure; 2018 Apr; 26(4):555-564.e3. PubMed ID: 29526431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Bispecific Lead Compounds from
    Kumar S; El-Kafrawy SA; Bharadwaj S; Maitra SS; Alandijany TA; Faizo AA; Khateb AM; Dwivedi VD; Azhar EI
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential Zika virus NS2B-NS3 protease inhibitors via docking, molecular dynamics and consensus scoring-based virtual screening.
    Bowen LR; Li DJ; Nola DT; Anderson MO; Heying M; Groves AT; Eagon S
    J Mol Model; 2019 Jun; 25(7):194. PubMed ID: 31209577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dynamics simulations of allosteric motions and competitive inhibition of the Zika virus helicase.
    Raubenolt BA; Wong K; Rick SW
    J Mol Graph Model; 2021 Nov; 108():108001. PubMed ID: 34388402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the Lead Compounds for Zika Virus NS2B-NS3 Protein: an e-Pharmacophore-Based Approach.
    Rohini K; Agarwal P; Preethi B; Shanthi V; Ramanathan K
    Appl Biochem Biotechnol; 2019 Jan; 187(1):194-210. PubMed ID: 29911269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidating the inhibitory mechanism of Zika virus NS2B-NS3 protease with dipeptide inhibitors: Insights from molecular docking and molecular dynamics simulations.
    Ullah S; Ullah F; Rahman W; Ullah A; Haider S; Yueguang C
    PLoS One; 2024; 19(8):e0307902. PubMed ID: 39116118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zika virus NS2B/NS3 proteinase: A new target for an old drug - Suramin a lead compound for NS2B/NS3 proteinase inhibition.
    Coronado MA; Eberle RJ; Bleffert N; Feuerstein S; Olivier DS; de Moraes FR; Willbold D; Arni RK
    Antiviral Res; 2018 Dec; 160():118-125. PubMed ID: 30393012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of New Zika Protease and Polymerase Inhibitors through the Open Science Collaboration Project OpenZika.
    Mottin M; de Paula Sousa BK; de Moraes Roso Mesquita NC; de Oliveira KIZ; Noske GD; Sartori GR; de Oliveira Albuquerque A; Urbina F; Puhl AC; Moreira-Filho JT; Souza GE; Guido RVC; Muratov E; Neves BJ; Martins da Silva JH; Clark AE; Siqueira-Neto JL; Perryman AL; Oliva G; Ekins S; Andrade CH
    J Chem Inf Model; 2022 Dec; 62(24):6825-6843. PubMed ID: 36239304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.